Skip to content

Prognostic impact of preoperative echocardiography in elderly patients with fragility hip Fracture: A Randomized Controlled Trial

Prognostic impact of preoperative echocardiography in elderly patients with fragility hip Fracture: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007636
Enrollment
160
Registered
2022-08-09
Start date
2022-09-01
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Echocardiography before surgery) : The study found that two treatment groups exist. The group that did not perform a preoperative echocardiogram was in the control group, and the group that per

Sponsors

The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) For adults over the age of 65 who undergo surgical treatment for fragility hip fractures. (2) ASA grade 3 or higher (1-3) (3) Koval activity grade 5 or higher (1-5) (4) Patients who are able to comply with and cooperate with outpatient follow-up, functional and radiological evaluation after surgery (5) A patient who understands the study and has given written consent by the patient's own or the patient's representative to participate in the study.

Exclusion criteria

Exclusion criteria: (1) Patients who have difficulty breathing, chest pain, fainting or significant dizziness or who have worsened within the last 3 months (2) ASA grade 4 and below (4-6) (3) Patients with a revised cardiac risk index of 3 or higher (4) Patients who were unable to walk independently prior to the fracture: Koval activity grade 6 or less (6-7) (5) Among ASA grade 3 patients, if you have cardiovascular disease (heart failure, heart valve disease, coronary artery disease, coronary artery interventional strength, artificial pacemaker/intra-heart device retention, dialysis patients, serious arrhythmias such as atrial fibrillation, chronic obstructive pulmonary disease, etc.) and the evaluation of heart function has not been carried out within the last 1 year. (6) If there was a previous local infection, sepsis, lower extremity vein thrombosis, etc. in the lower extremities at the surgical site (7) Patients with past surgical history in the hip joint (8) Patients who are not able to be tracked after alcohol and on an outpatient basis

Design outcomes

Primary

MeasureTime frame
Troponin-I, CK-MB, NT pro BNP level ;Hip x-ray;VAS Pain Score;Harris Hip Score ;Western Ontario and McMaster Universities Index (WOMAC index) ;EQ-5D index (Quality of life)

Secondary

MeasureTime frame
Cognitive function assessment score

Countries

Korea, Republic of

Contacts

Public ContactJi-eun Jeong

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

jje0455@naver.com+82-2-2030-4628

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026